Dermata Therapeutics, Inc. (DRMA) analyst actions
Rating and price-target actions on DRMA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the DRMA overview →
1 measured DRMA analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial | Press release | -0.07% | -3.00% |
Keep exploring
More DRMA: earnings → · SEC filings → · DRMA overview →